http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2130770-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0ef049605214ab2d6cbb74d055c351e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate | 1994-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6b2cbea348462ff27b47fb7768e3235 |
| publicationDate | 1995-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2130770-A1 |
| titleOfInvention | Treatment of upper respiratory tract infections |
| abstract | Abstract Novel Treatment Or Upper Respiratory Tract Infections The present invention relates to the use of sodium cromoglycate in the therapeutic treatment of the symptoms of upper respiratory tract infections (eg the common cold and influenza). |
| priorityDate | 1993-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.